SHE:300723 Revenue

ApicHope Pharmaceutical Group had revenue of 385.47M CNY in the quarter ending March 31, 2026, with 2.26% growth. This brings the company's revenue in the last twelve months to 940.78M, down -21.88% year-over-year. In the year 2025, ApicHope Pharmaceutical Group had annual revenue of 932.27M, down -35.72%.

Revenue (ttm)

940.78M

Revenue Growth

-21.88%

P/S Ratio

18.48

Revenue / Employee

633.95K

Employees

1,484

Market Cap

17.38B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	932.27M	-517.96M	-35.72%
Dec 31, 2024	1.45B	-1.05B	-42.07%
Dec 31, 2023	2.50B	223.25M	9.79%
Jan 1, 2023	2.28B	80.98M	3.68%
Dec 31, 2021	2.20B	523.80M	31.26%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shandong Buchang Pharmaceuticals	10.96B
Fujian Cosunter Pharmaceutical	430.98M
Guangdong Zhongsheng Pharmaceutical	2.45B
Wanbangde Pharmaceutical Holding Group	1.14B
China Resources Double-Crane Pharmaceutical	10.73B
Shenzhen Kangtai Biological Products	2.66B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	4.07B
Walvax Biotechnology	2.40B

Revenue Rankings